Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    11069252 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Safety, Tolerability, and Anti-HIV Activity of DMP 266 (Efavirenz) in Combination With Nelfinavir in HIV-Positive Children
Condition: HIV Infections
Interventions: Drug: Nelfinavir mesylate;   Drug: Efavirenz

Indicates status has not been verified in more than two years